FDA approves marketing of two drugs previously available under treatment IND regulations.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D015507:Drugs, Investigational; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*
D015507:Drugs, Investigational; D010627:Phenethylamines; D012642:Selegiline; D015774:Ganciclovir